Sorbitol Is a Severity Biomarker for <scp>PMM2‐CDG</scp> with Therapeutic ImplicationsAnna N. Ligezka, Éva Morava, William Brucker et al.|Annals of Neurology|2021Cited by 57
<scp>TRIT1</scp> defect leads to a recognizable phenotype of myoclonic epilepsy, speech delay, strabismus, progressive spasticity, and normal lactate levelsEwout Muylle, Éva Morava, Huafang Jiang et al.|Journal of Inherited Metabolic Disease|2022Cited by 18